BIB vs. DBE
BIB (ProShares Ultra Nasdaq Biotechnology) and DBE (Invesco DB Energy Fund) are both exchange-traded funds - BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%), while DBE is a Oil & Gas fund tracking the DBIQ Optimum Yield Energy Index. Both are passively managed. Over the past 10 years, BIB returned 8.89%/yr vs 11.45%/yr for DBE. At a 0.13 correlation, their price movements are largely independent. BIB charges 0.95%/yr vs 0.78%/yr for DBE.
Performance
BIB vs. DBE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIB achieves a 25.05% return, which is significantly lower than DBE's 68.39% return. Over the past 10 years, BIB has underperformed DBE with an annualized return of 8.89%, while DBE has yielded a comparatively higher 11.45% annualized return.
BIB
- 1D
- -0.48%
- 1M
- 20.02%
- 6M
- 23.45%
- YTD
- 25.05%
- 1Y
- 98.81%
- 3Y*
- 24.57%
- 5Y*
- 1.94%
- 10Y*
- 8.89%
DBE
- 1D
- -1.09%
- 1M
- 6.25%
- 6M
- 65.69%
- YTD
- 68.39%
- 1Y
- 57.64%
- 3Y*
- 17.96%
- 5Y*
- 17.10%
- 10Y*
- 11.45%
BIB vs. DBE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 25.05% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
DBE Invesco DB Energy Fund | 68.39% | -2.17% | 2.96% | -12.14% | 33.77% | 57.56% | -25.91% | 19.72% | -12.95% | 5.21% |
Correlation
The correlation between BIB and DBE is -0.28, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.05 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.13 |
The correlation between BIB and DBE shifts across timeframes, from -0.28 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIB vs. DBE — Risk / Return Rank
BIB
DBE
BIB vs. DBE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and Invesco DB Energy Fund (DBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIB | DBE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.84 | ||
| Sortino ratioReturn per unit of downside risk | +0.82 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.28 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 5.87 | 2.34 | +3.53 |
| Martin ratioReturn relative to average drawdown | 17.58 | 7.00 | +10.58 |
Loading charts...
Drawdowns
BIB vs. DBE - Drawdown Comparison
The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum DBE drawdown of -86.69%. Use the drawdown chart below to compare losses from any high point for BIB and DBE.
Loading charts...
Drawdown Indicators
| BIB | DBE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.24% | -86.69% | +19.45% |
Max Drawdown (1Y)Largest decline over 1 year | -16.92% | -24.72% | +7.80% |
Max Drawdown (3Y)Largest decline over 3 years | -45.30% | -24.72% | -20.58% |
Max Drawdown (5Y)Largest decline over 5 years | -65.86% | -38.74% | -27.12% |
Max Drawdown (10Y)Largest decline over 10 years | -66.20% | -60.84% | -5.36% |
Current DrawdownCurrent decline from peak | -9.18% | -36.07% | +26.89% |
Average DrawdownAverage peak-to-trough decline | -32.61% | -57.19% | +24.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.64% | 8.26% | -2.62% |
Volatility
BIB vs. DBE - Volatility Comparison
ProShares Ultra Nasdaq Biotechnology (BIB) and Invesco DB Energy Fund (DBE) have volatilities of 11.73% and 11.68%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIB | DBE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.73% | 11.68% | +0.05% |
Volatility (6M)Calculated over the trailing 6-month period | 31.63% | 32.70% | -1.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.67% | 35.99% | +4.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.78% | 29.88% | +13.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.32% | 28.39% | +17.93% |
BIB vs. DBE - Expense Ratio Comparison
BIB has a 0.95% expense ratio, which is higher than DBE's 0.78% expense ratio.
Dividends
BIB vs. DBE - Dividend Comparison
BIB's dividend yield for the trailing twelve months is around 0.32%, less than DBE's 2.29% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.32% | 0.77% | 1.69% | 0.07% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% |
DBE Invesco DB Energy Fund | 2.29% | 3.86% | 6.32% | 3.87% | 0.75% | 0.00% | 0.00% | 1.79% | 1.67% |
Frequently Asked Questions
BIB and DBE have a correlation of -0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIB has higher volatility (11.73%) compared to DBE (11.68%). In terms of maximum drawdown, BIB dropped -67.24% vs DBE's -86.69%.
On 10-year performance, DBE leads with 11.45% vs 8.89% for BIB. On fees, DBE is cheaper at 0.78% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, DBE has performed better with a 11.45% return vs 8.89%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
DBE is cheaper with a 0.78% expense ratio, compared with 0.95% for BIB.
DBE has the higher dividend yield at 2.29%, compared with 0.32% for BIB.
BIB is categorized as Leveraged Equities, while DBE is Oil & Gas. BIB tracks NASDAQ Biotechnology Index (200%), while DBE tracks DBIQ Optimum Yield Energy Index. They also come from different issuers: ProShares and Invesco. Their fees differ too: 0.95% for BIB and 0.78% for DBE.
BIB currently has the higher Sharpe Ratio (2.45 vs 1.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIB and DBE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer